Improved mortality in CV patients

[Apoplexy__]

---

Members don't see this ad.

I'm getting confused as to which drugs improve mortality when in patients with cardiovascular disease. My understanding is this:

-B-blockers improve long-term mortality of a post-MI patient, with or without symptoms of CHF (as long as it's not decompensated)
-ACE inhibitors reduce cardiac remodeling, but I'm not sure if they'd be an answer choice for "improving mortality"...
-Spironolactone improves mortality in late-stage CHF patients when added in a low-dose to a regimen of digoxin+diuretic+ACE inhibitor.

How does that sound? Are there any others I should know? I seem to struggle with every "improves mortality" question I get on UWorld.

 

[MudPhud20XX]

Definitely spironolactone is important and I think you are right about it. I remember Conrad Fischer mentioning it. Hope others can help us out.

 

[Missorleans]

I think DIT listed all of those as improving mortality in cardiac patients. There was one group, I think diuretics (other than spironolactone) do not improve mortality, just help symptoms. Also digoxin does not improve mortality.